Qm. Wang et al., DEVELOPMENT OF IN-VITRO PEPTIDE-SUBSTRATES FOR HUMAN RHINOVIRUS-14 2APROTEASE, Archives of biochemistry and biophysics (Print), 356(1), 1998, pp. 12-18
Purified 2A protease from human rhinovirus serotype-14 (HRV14) was una
ble to efficiently cleave a 16-mer peptide representing its authentic
cis-cleavage site on the viral polyprotein, implying that in vivo cis
cleavage by this enzyme might be very different from its in vitro tran
s activity. Presence of a serine at position P2 and a leucine at P2' i
n the 16-mer peptide was found to be responsible for the low peptide c
leavage efficiency. To search for an efficient peptide substrate for H
RV14 2A, small peptides derived from other rhinovirus 2A protease clea
vage sites were synthesized and tested. These results suggested that t
he N-terminal 8 amino acids were sufficient for HRV14 2A cleavage to o
ccur, although the P1' and P2' residue identities were important to th
e cleavage of peptides with amino acids occupying both sides of the sc
issile bond. On the basis of the 2A substrate requirements, a sensitiv
e fluorometric assay for the viral 2A proteases was developed using pe
ptides with anthranilide and 3-nitrotyrosine as the resonance energy t
ransfer donor/quencher pair. Our data indicated that these fluorescent
peptide substrates were suitable for 2A protease characterization and
inhibitor evaluation. (C) 1998 Academic Press.